However, due to the limitation of VEGF-siRNA with sole silencing function, we postulate that ppp-RNA orchestrating RIG-I activation to VEGF-siRNA (ppp-VEGF), should be a good solution and a novel strategy for cancer therapy. Here, RIGI is linked to cancer.